Skip to main content
PMGC Holdings Inc. logo

PMGC Holdings Inc. — Investor Relations & Filings

Ticker · ELAB ISIN · US73017P3001 US Financial and insurance activities
Open in API
Filings indexed 242 across all filing types
Latest filing 2025-04-24 Capital/Financing Update
Country US United States of America
Listing US ELAB

About PMGC Holdings Inc.

https://pmgcholdings.com/

PMGC Holdings Inc. is a diversified holding company that acquires and manages cash-flowing businesses, with a primary focus on the manufacturing sector. The company operates under a long-term 'permanent capital' philosophy, aiming to preserve and grow the legacy of its acquired companies. Its strategy involves collaborating with existing founders and management teams, providing financial resources and a supportive platform to foster sustained value creation while maintaining operational continuity. PMGC Holdings actively seeks acquisitions to expand its portfolio, which includes companies in packaging and precision engineering.

Recent filings

Filing Released Lang Actions
PROSPECTUS SUPPLEMENT
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) under the Securities Act of 1933. It details an at-the-market equity offering of common stock by PMGC Holdings Inc., including terms of the offering, the sales agreement with the sales agent, and related risk factors. The document is a formal disclosure related to capital raising activities and securities issuance. It is not a financial report, earnings release, management discussion, or any other type of report. It is a capital markets document specifically about financing and equity issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering terms, confirming it is not merely an announcement but the actual prospectus supplement for the offering.
2025-04-24 English
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It reports a non-binding Letter of Intent entered into by the company and includes a press release as an exhibit. The document does not contain detailed financial statements or comprehensive financial data but rather announces a corporate event. The length is 4241 characters, which is relatively short and consistent with a current report rather than a full financial report. The content fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into more specific categories like earnings release or management report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-04-16 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-04-16 English
Regulatory Filings 2025
Regulatory Filings
2025-04-11 English
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It reports a Development and License Agreement between Northstrive Biosciences Inc. and YuvaBio Biosciences, Inc. The content focuses on the description of the agreement, terms, intellectual property rights, payments, and related details. There are no financial statements or earnings data presented, nor is it an annual or quarterly report. The document is not a proxy, voting result, or management change announcement. It is a regulatory filing reporting a material event (a contract agreement) that is significant to investors and the market. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is over 12,000 characters, indicating it is a full filing, not just a brief announcement or press release. Confidence is high due to the clear identification as a Form 8-K and the nature of the content.
2025-04-10 English
AMENDMENT NO. 1 TO FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A (Amendment No. 1) filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It details amendments to consulting agreements with the Non-Executive Chairman and Non-Employee CEO, including compensation terms and shareholder approval conditions. The document does not contain financial statements or comprehensive financial data but rather reports material definitive agreements entered into by the company. The filing is an amendment to a previously filed Form 8-K, correcting the item heading and providing details about the agreements. This type of filing is best classified under Regulatory Filings (RNS) as it is a current report amendment disclosing material agreements and does not fit into other specific categories such as Annual Report, Earnings Release, or Management Reports.
2025-04-08 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.